“Examining the Therapeutic Potential of CRISPR-Cas9 Gene Editing in Spondyloarthritis: Efficacy of TNF Inhibitor Adalimumab: Research Article”. International Journal of Research in Medical and Clinical Science, vol. 2, no. 02, July 2024, pp. 20-30, https://doi.org/10.70829/ijrmcs.v2.i2.0724002.